J Cell Sci. 2010 Nov 15;123(Pt 22):3893-900. doi: 10.1242/jcs.072157. Epub 2010 Oct 27.
Specific phosphorylation of Ser458 of A-type lamins in LMNA-associated myopathy patients.
Mutations in LMNA, which encodes A-type nuclear lamins, cause various human diseases, including myopathy, cardiomyopathy, lipodystrophy and progeria syndrome. To date, little is known about how mutations in a single gene cause a wide variety of diseases. Here, by characterizing an antibody that specifically recognizes the phosphorylation of Ser458 of A-type lamins, we uncover findings that might contribute to our understanding of laminopathies. This antibody only reacts with nuclei in muscle biopsies from myopathy patients with mutations in the Ig-fold motif of A-type lamins. Ser458 phosphorylation is not seen in muscles from control patients or patients with any other neuromuscular diseases. In vitro analysis confirmed that only lamin A mutants associated with myopathy induce phosphorylation of Ser458, whereas lipodystrophy- or progeria-associated mutants do not. We also found that Akt1 directly phosphorylates Ser458 of lamin A with myopathy-related mutations in vitro. These results suggest that Ser458 phosphorylation of A-type lamins correlates with striated muscle laminopathies; this might be useful for the early diagnosis of LMNA-associated myopathies. We propose that disease-specific phosphorylation of A-type lamins by Akt1 contributes to myopathy caused by LMNA mutations.
Aタイプ-ラミンをコードするLMNA遺伝子の変異は、ミオパチー以外に、心筋症、リポジストロフィー、早老症などの病型で認められる。458番目のセリン （Ser458) のリン酸化を認識する抗体を用いて、Ser458のリン酸化障害が骨格筋特異的な臨床症状とリンクすることを示した。